Seagen (Canada)

Seagen (Canada)

Seagen Inc. is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Seagen (Canada), Canada, covering academic research published from 2002 to 2023. Read More.


Open Access Percentage

77%


Total
Publications

79


Total Open
Publications

61


Total
Citations

5.3K


Open Access
Percentage

77%


Total
Publications

79


Total Open
Publications

61


Total
Citations

5.3K

Wikipedia

Website

download

Breakdown

29% 32% 16% 23%

Publisher Open

29%

Both

32%

Other Platform Open

16%

Closed

23%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

01234567891011Total Publications
2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

14%OA Journal

OA Journal 14%

7

Hybrid 17%

8

No Guarantees 69%

33

Other Platform Open

Domain 89%

34

Institution 21%

8

Preprint 5%

2

Other Internet 5%

2

Public 3%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
33
Europe PMC
Domain
23
University of Southern Denmark - University of Southern Denmark Research Portal
Institution
2
University of Michigan - Deep Blue
Institution
2
Research Square
Preprint
2
Harvard University - Digital Access to Scholarship at Harvard (DASH)
Institution
2
University of Toronto - TSpace
Institution
1
University of Szeged - SZTE Publicatio Repozitórium - SZTE - Repository of Publications
Institution
1
University of Debrecen - University of Debrecen Electronic Archive
Institution
1
University of California - eScholarship University of California
Institution
1
1 / 2

Data updated 8 December 2024

Share

Share

Share